For the quarter ending 2026-03-31, OPCH had -$55,303K decrease in cash & cash equivalents over the period. -$21,156K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Infusion services net revenue | - | 1,440,538 | - | - |
| Other revenue | - | 24,908 | - | - |
| Total option care health revenue | 1,350,654 | 1,465,446 | - | - |
| Cost of net revenues - drugs | 949,364 | 1,031,032 | - | - |
| Salaries, benefits, and other employee expense | 216,593 | 216,515 | - | - |
| Other segment items | 97,245 | 107,138 | - | - |
| Depreciation and amortization expense | 14,907 | 19,260 | - | - |
| Interest expense, net | 13,304 | 12,734 | - | - |
| Equity in earnings of joint ventures | 1,689 | 2,109 | - | - |
| Other, net | 73 | 640 | - | - |
| Income tax expense | 15,660 | 23,012 | - | - |
| Net income | 45,343 | 58,504 | 51,816 | 50,523 |
| Depreciation and amortization expense | 15,655 | 20,316 | 17,048 | 16,953 |
| Non-cash operating lease costs | 5,175 | 5,252 | 5,093 | 5,661 |
| Deferred income taxes, net | 1,866 | 6,000 | 809 | 264 |
| Loss on extinguishment of debt | - | 0 | -4,744 | 0 |
| Amortization of deferred financing costs | 683 | 692 | 1,140 | 1,168 |
| Equity in earnings of joint ventures | 1,689 | 2,109 | 2,176 | 1,395 |
| Stock-based incentive compensation expense | 10,199 | 9,318 | 11,125 | 10,712 |
| Distribution from equity method investments | - | 1,900 | 500 | 1,600 |
| Other adjustments | 391 | 1,468 | 309 | 205 |
| Accounts receivable, net | 42,870 | -837 | -5,962 | 4,604 |
| Inventories | -55,463 | 56,570 | 12,181 | 34,508 |
| Prepaid expenses and other current assets | -1,233 | 6,938 | -7,088 | 10,838 |
| Accounts payable | -93,246 | 9,299 | 38,128 | 60,197 |
| Accrued compensation and employee benefits | -20,982 | -2,046 | -392 | 23,188 |
| Accrued expenses and other current liabilities | 16,148 | -5,940 | 11,982 | -23,651 |
| Operating lease liabilities | 5,861 | 5,916 | 5,515 | 4,647 |
| Other noncurrent assets and liabilities | -382 | -1,824 | -3,957 | 495 |
| Net cash used in operating activities | -12,110 | 35,891 | 139,437 | 90,333 |
| Acquisition of property and equipment | 9,046 | 13,646 | 9,195 | 9,095 |
| Proceeds from sale of assets | - | 0 | - | - |
| Business acquisitions, net of cash acquired | 0 | 0 | 0 | -75 |
| Other investing activities | 274 | 0 | 2,529 | - |
| Net cash used in investing activities | -9,320 | -13,646 | -11,724 | -9,020 |
| Stock-based compensation tax withholdings | 12,595 | 2,683 | 16 | 515 |
| Purchase of company stock and related excise taxes | - | 95,064 | 62,458 | 152,429 |
| Repayments of debt principal | - | - | 3,255 | - |
| Proceeds from issuance of debt | - | 0 | 229,472 | 0 |
| Purchase of company stock, and related excise taxes | 17,539 | - | - | - |
| Repayments of debt principal | 1,695 | 1,696 | - | 1,627 |
| Retirement of debt obligations | - | 0 | 180,239 | - |
| Deferred financing costs | 2,044 | 0 | 3,382 | 0 |
| Other financing activities | 0 | 0 | -86 | 482 |
| Net cash used in financing activities | -33,873 | -99,443 | -16,709 | -53,867 |
| Net decrease in cash and cash equivalents | -55,303 | -77,198 | 111,004 | 27,446 |
| Cash and cash equivalents - beginning of period | 232,624 | 309,822 | 198,818 | 171,372 |
| Cash and cash equivalents - end of period | 177,321 | 232,624 | 309,822 | 198,818 |
Option Care Health, Inc. (OPCH)
Option Care Health, Inc. (OPCH)